SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-149464
Filing Date
2018-05-03
Accepted
2018-05-03 06:35:56
Documents
2
Period of Report
2018-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d576467d8k.htm 8-K 15815
2 EX-99.1 d576467dex991.htm EX-99.1 75213
  Complete submission text file 0001193125-18-149464.txt   92112
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 18801701
SIC: 2834 Pharmaceutical Preparations